BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16913546)

  • 1. Cost-effectiveness of treatments for dysfunctional uterine bleeding.
    Wade SW; Magee G; Metz L; Broder MS
    J Reprod Med; 2006 Jul; 51(7):553-62. PubMed ID: 16913546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Payer cost savings with endometrial ablation therapy.
    London R; Holzman M; Rubin D; Moffitt B
    Am J Manag Care; 1999 Jul; 5(7):889-97. PubMed ID: 10557409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial and quality-of-life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment.
    Frick KD; Clark MA; Steinwachs DM; Langenberg P; Stovall D; Munro MG; Dickersin K;
    Womens Health Issues; 2009; 19(1):70-8. PubMed ID: 19111789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception.
    Blumenthal PD; Trussell J; Singh RH; Guo A; Borenstein J; Dubois RW; Liu Z
    Contraception; 2006 Sep; 74(3):249-58. PubMed ID: 16904420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: a randomized controlled trial.
    Dickersin K; Munro MG; Clark M; Langenberg P; Scherer R; Frick K; Zhu Q; Hallock L; Nichols J; Yalcinkaya TM;
    Obstet Gynecol; 2007 Dec; 110(6):1279-89. PubMed ID: 18055721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids.
    Beinfeld MT; Bosch JL; Isaacson KB; Gazelle GS
    Radiology; 2004 Jan; 230(1):207-13. PubMed ID: 14695395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of hysteroscopic endometrial ablation versus vaginal hysterectomy for menorrhagia.
    Vilos GA; Pispidikis JT; Botz CK
    Obstet Gynecol; 1996 Aug; 88(2):241-5. PubMed ID: 8692509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial ablation versus hysterectomy: STOP-DUB.
    Weber AM; Munro MG
    Medscape Womens Health; 1998 May; 3(3):3. PubMed ID: 9732095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment of dysfunctional uterine bleeding.
    Bongers MY; Mol BW; Brölmann HA
    Maturitas; 2004 Mar; 47(3):159-74. PubMed ID: 15036486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term effect on radiofrequency heat-coagulation endometrial ablation in the treatment of anovulatory dysfunctional uterine bleeding].
    Yin GP; Li J; Zhu TY; Chen M; Yang SJ; Zhao XL
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):664-8. PubMed ID: 22176990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi.
    Floyd K; Skeva J; Nyirenda T; Gausi F; Salaniponi F
    Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S29-37. PubMed ID: 12971652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermal balloon endometrial ablation for dysfunctional uterine bleeding: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(11):1-89. PubMed ID: 23074450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial.
    Volkers NA; Hehenkamp WJ; Smit P; Ankum WM; Reekers JA; Birnie E
    J Vasc Interv Radiol; 2008 Jul; 19(7):1007-16; quiz 1017. PubMed ID: 18589314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa.
    Sinanovic E; Floyd K; Dudley L; Azevedo V; Grant R; Maher D
    Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S56-62. PubMed ID: 12971655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding.
    Munro MG; Dickersin K; Clark MA; Langenberg P; Scherer RW; Frick KD;
    Menopause; 2011 Apr; 18(4):445-52. PubMed ID: 21701431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hysterectomy vs. resectoscopic endometrial ablation for the control of abnormal uterine bleeding. A cost-comparative study.
    Brooks PG; Clouse J; Morris LS
    J Reprod Med; 1994 Oct; 39(10):755-60. PubMed ID: 7837119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients.
    Gallinat A
    J Reprod Med; 2007 Jun; 52(6):467-72. PubMed ID: 17694962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of strategies to evaluate postmenopausal bleeding.
    Feldman S; Berkowitz RS; Tosteson AN
    Obstet Gynecol; 1993 Jun; 81(6):968-75. PubMed ID: 8497365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids.
    Dembek CJ; Pelletier EM; Isaacson KB; Spies JB
    J Vasc Interv Radiol; 2007 Oct; 18(10):1207-13. PubMed ID: 17911509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.